# Leukemia

**Type:** Journals  
**Canonical URL:** https://scholariq.org/journals/leukemia/

## Facts

| Field | Value |
| --- | --- |
| Open Access | false |
| ISSN-L | 0887-6924 |
| ISSNs | 0887-6924,1476-5551 |
| OpenAlex ID | https://openalex.org/S149476849 |
| Publisher | Springer Nature |

## Journal papers

Showing 12 of 49.

- [European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia](https://scholariq.org/papers/european-leukemianet-2020-recommendations-for-treating-chronic-myeloid-leukemia/)
- [Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease](https://scholariq.org/papers/standardized-rt-pcr-analysis-of-fusion-gene-transcripts-from-chromosome/)
- [B-cell maturation antigen (BCMA) in multiple myeloma: rationale for targeting and current therapeutic approaches](https://scholariq.org/papers/b-cell-maturation-antigen-bcma-in-multiple-myeloma-rationale-for-targeting-and/)
- [Results of NOPHO ALL2008 treatment for patients aged 1–45 years with acute lymphoblastic leukemia](https://scholariq.org/papers/results-of-nopho-all2008-treatment-for-patients-aged-1-45-years-with-acute/)
- [Azacitidine for treatment of imminent relapse in MDS or AML patients after allogeneic HSCT: results of the RELAZA trial](https://scholariq.org/papers/azacitidine-for-treatment-of-imminent-relapse-in-mds-or-aml-patients-after/)
- [Trends in overall survival and costs of multiple myeloma, 2000–2014](https://scholariq.org/papers/trends-in-overall-survival-and-costs-of-multiple-myeloma-2000-2014/)
- [Screening for MLL tandem duplication in 387 unselected patients with AML identify a prognostically unfavorable subset of AML](https://scholariq.org/papers/screening-for-mll-tandem-duplication-in-387-unselected-patients-with-aml/)
- [Novel insight into stem cell mobilization-Plasma sphingosine-1-phosphate is a major chemoattractant that directs the egress of hematopoietic stem progenitor cells from the bone marrow and its level in peripheral blood increases during mobilization due to activation of complement cascade/membrane attack complex](https://scholariq.org/papers/novel-insight-into-stem-cell-mobilization-plasma-sphingosine-1-phosphate-is-a/)
- [The concept of treatment-free remission in chronic myeloid leukemia](https://scholariq.org/papers/the-concept-of-treatment-free-remission-in-chronic-myeloid-leukemia/)
- [Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia](https://scholariq.org/papers/increased-proportion-of-mature-nk-cells-is-associated-with-successful-imatinib/)
- [LocoMMotion: a prospective, non-interventional, multinational study of real-life current standards of care in patients with relapsed and/or refractory multiple myeloma](https://scholariq.org/papers/locommotion-a-prospective-non-interventional-multinational-study-of-real-life/)
- [Peripheral artery occlusive disease in chronic phase chronic myeloid leukemia patients treated with nilotinib or imatinib](https://scholariq.org/papers/peripheral-artery-occlusive-disease-in-chronic-phase-chronic-myeloid-leukemia/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.